nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel guluronate oligomer improves intestinal transit and survival in cystic fibrosis mice
|
Vitko, Megan |
|
2016 |
15 |
6 |
p. 745-751 7 p. |
artikel |
2 |
A product of immunoreactive trypsinogen and pancreatitis-associated protein as second-tier strategy in cystic fibrosis newborn screening
|
Weidler, Sophia |
|
2016 |
15 |
6 |
p. 752-758 7 p. |
artikel |
3 |
Bioelectrical impedance in young patients with cystic fibrosis: Validation of a specific equation and clinical relevance
|
Charatsi, A.M. |
|
2016 |
15 |
6 |
p. 825-833 9 p. |
artikel |
4 |
Biomarkers for cystic fibrosis drug development
|
Muhlebach, Marianne S. |
|
2016 |
15 |
6 |
p. 714-723 10 p. |
artikel |
5 |
Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation
|
Sermet-Gaudelus, Isabelle |
|
2016 |
15 |
6 |
p. e67-e69 nvt p. |
artikel |
6 |
Continuous alternating inhaled antibiotics for chronic pseudomonal infection in cystic fibrosis
|
Flume, Patrick A. |
|
2016 |
15 |
6 |
p. 809-815 7 p. |
artikel |
7 |
Continuous alternating inhaled antibiotic therapy in CF: A single center retrospective analysis
|
Van de Kerkhove, C. |
|
2016 |
15 |
6 |
p. 802-808 7 p. |
artikel |
8 |
Coronary artery disease in cystic fibrosis: An emerging concern?
|
Skolnik, Kate |
|
2016 |
15 |
6 |
p. e70-e71 nvt p. |
artikel |
9 |
CT-abnormalities, bacteriology and symptoms of sinonasal disease in children with Cystic Fibrosis
|
Berkhout, M.C. |
|
2016 |
15 |
6 |
p. 816-824 9 p. |
artikel |
10 |
Cystic fibrosis biomarker — Commentary
|
Durmowicz, Anthony G. |
|
2016 |
15 |
6 |
p. 712-713 2 p. |
artikel |
11 |
Cystic fibrosis in Latin America—Improving the awareness
|
Silva Filho, Luiz Vicente Ribeiro F. |
|
2016 |
15 |
6 |
p. 791-793 3 p. |
artikel |
12 |
Early pulmonary disease manifestations in cystic fibrosis mice
|
Darrah, Rebecca J. |
|
2016 |
15 |
6 |
p. 736-744 9 p. |
artikel |
13 |
Editorial Board
|
|
|
2016 |
15 |
6 |
p. ii- 1 p. |
artikel |
14 |
Enteral tube feeding for individuals with cystic fibrosis: Cystic Fibrosis Foundation evidence-informed guidelines
|
Schwarzenberg, Sarah Jane |
|
2016 |
15 |
6 |
p. 724-735 12 p. |
artikel |
15 |
Equitable CF care as a basic human right
|
De Boeck, Kris |
|
2016 |
15 |
6 |
p. 703-704 2 p. |
artikel |
16 |
Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis
|
Cohen-Cymberknoh, Malena |
|
2016 |
15 |
6 |
p. 776-782 7 p. |
artikel |
17 |
Extensive cultivation of soil and water samples yields various pathogens in patients with cystic fibrosis but not Burkholderia multivorans
|
Peeters, Charlotte |
|
2016 |
15 |
6 |
p. 769-775 7 p. |
artikel |
18 |
IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infection
|
Bayes, Hannah K. |
|
2016 |
15 |
6 |
p. 759-768 10 p. |
artikel |
19 |
Improving inhaled antibiotic treatment – Practice defeats the proof
|
van der Ent, C Kors |
|
2016 |
15 |
6 |
p. 705-707 3 p. |
artikel |
20 |
Long-term work participation among cystic fibrosis patients undergoing lung transplantation
|
Krivchenia, Katelyn |
|
2016 |
15 |
6 |
p. 846-849 4 p. |
artikel |
21 |
News
|
|
|
2016 |
15 |
6 |
p. 710-711 2 p. |
artikel |
22 |
Nutrition in CF — Two new important guidelines
|
Wolfe, Susan P |
|
2016 |
15 |
6 |
p. 708-709 2 p. |
artikel |
23 |
Probability of IV antibiotic retreatment within thirty days is associated with duration and location of IV antibiotic treatment for pulmonary exacerbation in cystic fibrosis
|
VanDevanter, D.R. |
|
2016 |
15 |
6 |
p. 783-790 8 p. |
artikel |
24 |
Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis
|
Collaco, Joseph M. |
|
2016 |
15 |
6 |
p. 794-801 8 p. |
artikel |
25 |
Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis — Results of a multicenter, prospective, randomized, double-blind, controlled trial
|
Mainz, Jochen G. |
|
2016 |
15 |
6 |
p. e57-e66 nvt p. |
artikel |
26 |
Ursodeoxycholic acid treatment is associated with improvement of liver stiffness in cystic fibrosis patients
|
van der Feen, Cathelijne |
|
2016 |
15 |
6 |
p. 834-838 5 p. |
artikel |
27 |
Variation of glucose tolerance in adult patients with cystic fibrosis: What is the potential contribution of insulin sensitivity?
|
Boudreau, Valérie |
|
2016 |
15 |
6 |
p. 839-845 7 p. |
artikel |